Clinical trial
A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic…
NCT00156689 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00156689 |
|---|---|
| Title | A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic Idiopathic Axonal Polyneuropathy. |
| Official title | A Pilot Study in a Double Blind, Randomized, Placebo-Controlled, Parallel-Group, 16 Week, Trial Design Evaluating the Efficacy and Safety of Levetiracetam 500 mg Tablets in Bid Administration (Daily Dose Ranging From 1000 mg to 3000 mg), in Adults (>18 Years of Ages) Suffering From Chronic… |
| Lead sponsor | Vanderbilt University, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Idiopathic Axonal Polyneuropathy |
| Intervention type | Drug |
| Interventions | levetiracetam |
| Enrollment | 30 |
| Start date | Aug 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 11, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: